Health Research Inc

“The Annual Form 990 is initiated by the Assistant Controller and developed in conjunction with the Controller and the Executive Director. The final draft is reviewed by the three key personnel listed above. A comparative analysis to the prior year's filing is conducted and then the final draft is presented to Health Research, Inc's independent audit firm for validation. Once finalized by the independent audit firm, the Executive Director presents and reviews the Form 990 filing with the Corporation's Secretary/Treasurer and if requested, the Corporation's Vice President. A copy of the 990 is provided to all Directors of the HRI Board for their review prior to filing.”

“HRI Conflict of Interest Policies are reviewed annually and if appropriate, revised by the Corporation's Counsel and Executive Director. The most recent version of the HRI Employee Conflict of Interest Policy was updated in January 2018. The policy is provided to employees on an annual basis via HRI's online training system. Individuals are required to attest to reading the policy; confirmation of which is electronically maintained by Corporate Human Resource Staff. In addition to the annual certification, all new employees are provided with a copy of Employee Conflict of Interest Policy in conjunction with New Hire Orientation, and the policy is available on the HRI website. All potential conflicts must be disclosed in writing to the Corporate Office for review and consideration by management. Compliance with the provisions of the policy are monitored and ensured through the presence of complimentary controls, such as the HRI Outside Employment Policy and Honoraria/Travel Expense Reimbursement Policy. Annually, members of the Board of Directors, Officers and Key employees are provided with a copy of the Conflict of Interest Policy for Board Members, Officers and Key Employees and must certify that they have read and understand the policy, in addition to disclosing all conflicts of interest. New HRI Board Members, Officers and Key Employees are provided with a copy of the policy at the time of appointment and are required to disclose any conflicts upon receipt. Attestations and disclosure forms are sent to the HRI Corporate Office. Restrictions imposed are conditioned and determined by circumstances and range from denial of the request for an employee to recusal for a Director of the Corporation.”

“Salaries of the Executive Director and all key employees are set in the annual budget. This is reviewed and approved by the Board annually.”

“Health Research, Inc.'s governing documents: Conflict of Interest Policy, Ethics Policy, Whistleblower Policy and Financial Statements are available to the public upon request.”

“Building a healthier future for New York State and beyond through the delivery of funding and program support to further public health and research programs. Administer gifts and grants in keeping with the health research, prevention, and treatment purpose of the New York State Department of Health (NYSDOH), the Roswell Park Cancer Institute Corporation (RPCIC) and other health related public and private entities; also including intellectual property management and technology transfer.”

“The following awards highlight a few of the new sponsored projects that Health Research, Inc has received funding for during the reporting period: Enhancing Reviews and Surveillance to Eliminate Maternal Mortality This award supports the capacity for developing and implementing data-informed strategies to prevent pregnancy-related deaths and reduce disparities among disproportionately impacted populations by improving data availability and quality to better identify and characterize pregnancy-related deaths and related health inequities. This award will also support agencies and organizations that coordinate and manage Maternal Mortality Review Committees to identify and characterize pregnancy-related deaths for prevention. Expanding Drug Checking Services Across New York This award supports community-based sites to test drug samples for toxic additives and provide harm reduction interventions to hard-to-reach populations that use drugs. The data collected in the community will be used to implement and expand the New York State drug surveillance program. Surveillance of Spina Bifida Across the Lifespan This award funds the development of population-based surveillance of individuals of all ages with spina bifida living in the fourteen counties in New York State with active birth defect surveillance programs to estimate prevalence, mortality, and survival of all age groups. HRI/NYSDOH will develop a new spina bifida surveillance framework comprised of cases identified using state birth defects surveillance program (NYS Birth Defects Registry) information and linked to records from clinics, hospital inpatient and outpatient data, Medicaid data, vital records data, and the National Death Index. Outcomes of this project include an increased availability of Spina Bifida (SB) data to inform clinical care and public health materials, programs and interventions. An improved understanding among public health and clinical researchers and providers on SB prevalence, age-specific mortality, and cause of death. Also, improved accuracy and efficiency in SB case-finding, reporting, and outcome predictions. Development of polymer-based cell culture substrates for correlative light and electron microscopy (CLEM) This award will provide previously unavailable polymer-based indexing-patterned substrates and enable imaging technology of correlative light and electron microscopy (CLEM) for convenient applications in structure-function studies to address questions in cell biology, tissue engineering, and regenerative medicines. These substrates can also serve as the scaffold for 3D growth in cells and organoids that recapitulate in vivo-like morphology and function, leading to better understanding of diseases at molecular, subcellular, cellular, tissue, and organoid levels.”

“The New York State Department of Health AIDS Institute established the Office of Uninsured Care Programs (the Programs) to provide access to medications and medical services for uninsured or underinsured New York State residents living with or at risk of acquiring HIV who meet established eligibility criteria. The AIDS Drug Assistance Program (ADAP) began in 1987 as part of a national program to provide free HIV/AIDS drugs to low-income individuals not covered by Medicaid or adequate third-party insurance. New York State expanded the program to include ambulatory care and home care services, insurance continuation and pre-exposure prophylaxis. The programs are funded through partnerships between the State and federal governments and between the State and the New York City, Long Island and Lower Hudson Ryan White Part A regions. Both federal and state statute/regulation governs the programs. The federal Ryan White HIV/AIDS Treatment Extension Act of 2009 includes statutory authority for AIDS Drug Assistance Programs throughout the nation, and associated appropriations provide federal funding to support the programs. In addition, State regulation in NYCRR, Title 10, Sub-part 43-2 governs the application and eligibility determination process and establishes the rights and responsibilities of applicants, participants, and providers. The Programs employ a dual approach to carry out their mission. First, the Programs empower the individual to seek and access care by allowing the individual to choose a provider and receive care/drugs without cost. Second, the Programs supply a stable and timely funding stream to health care providers, enabling them to use the revenues to develop program capacity to meet the needs of uninsured and underinsured people. The Programs are a key component in New York State's response to the HIV/AIDS epidemic. The Programs provide rapid access to antiretroviral (ARV) therapy and ensure universal access to care that is essential to improve health outcomes, achieve viral suppression, and reduce the risk of transmission. The Programs are comprised of five components: ADAP (AIDS Drug Assistance Program) provides free medications for the treatment of HIV/AIDS and opportunistic infections. ADAP Plus provides free primary care services at selected clinics, hospital outpatient departments, office-based physicians, and laboratory vendors. HIV Home Care Program provides coverage for home care services to chronically medically dependent individuals as ordered by their physician. ADAP Plus Insurance Continuation (APIC) can pay health insurance premiums for ADAP-eligible clients. PrEP-AP to prevent HIV infection by providing access to basic primary care services to support HIV-negative individuals at risk of acquiring HIV. The Programs can serve as a transition to Medicaid by providing interim assistance to persons eligible for but not yet enrolled in Medicaid or assist in meeting spend-down requirements. Individuals with health insurance who need assistance with meeting their deductibles or co-payments are also eligible. The Programs will coordinate benefits with their insurance company. Ryan White HIV/AIDS Program (RWHAP) legislation defers to individual states to define what qualifies as low-income eligibility and any additional program restrictions. New York State has codified its responsibilities under the Department of Health Administrative Rules and Regulations State Aid and Funding subchapter (10 CRR-NY 43-2) most recently updated in 2019. The UCP enrollment process has been revised to facilitate same-day enrollment for all participating providers, as well as applicants who apply on their own. The addition of this expansion decreases the program approval time for participants allowing for expedited ART, in accordance with the AIDS Institute policy on Rapid Initiation of Antiretroviral Therapy, which identifies every new diagnosis as an immediate call to action for every provider, with the goal of rapid initiatio”

“The Centers for Disease Control and Prevention (CDC) Public Health Emergency Preparedness (PHEP), the Administration for Strategic Preparedness and Response (ASPR) Hospital Preparedness Program (HPP), and ASPR Medical Reserve Corps State, Territory and Tribal Nations, Representative Organizations for Next Generation (MRC-STRONG) funding supports the efforts of the New York State Department of Health (NYSDOH) Office of Health Emergency Preparedness (OHEP). NYSDOH OHEP continues to work with the State Office of Emergency Management (State OEM) and other State Agencies, Local Health Departments (LHD) and private and public-sector partners to build a solid emergency preparedness and response foundation to respond to any crisis or emergent situation in the State. NYSDOH OHEP operates an integrated and comprehensive health emergency preparedness program, and these efforts can be categorized across several areas. 1. Planning and Assessment: NYSDOH OHEP creates plans and conducts assessments to address different aspects or contingencies of health emergency preparedness. NYSDOH OHEP works collaboratively with stakeholders and internal/external partners such as Regional Offices (RO)s, LHDs, clinical advisors, and others to develop these plans and assessments. Accomplishments from the period 04/01/2024 to 03/31/2025: NYSDOH OHEP in collaboration with Health Care Coalition (HCC) Readiness and Response Coordinators completed a coalition level Readiness Assessment in conjunction with coalition partners by January 31, 2025, Budget Period (BP) 1. NYSDOH OHEP in collaboration with HCC Readiness and Response Coordinators completed a coalition level Hazard Vulnerability Assessment (HVA) in conjunction with coalition partners by January 31, 2025 (BP1). NYSDOH OHEP collaborated with HCC Readiness and Response Coordinators in identifying and updating any planning gaps for all four (4) Health Emergency Preparedness Coalition (HEPC), Emergency Operations Plans (EOPs). NYSDOH OHEP reviewed de-identified emPOWER data to conduct risk planning for the needs of electricity-dependent individuals and updated the NYSDOH Health Emergency Preparedness and Response Plan (HEPRP). NYSDOH in collaboration with the All-hazards Planning Workgroup (AHPWG), Emergency Support Function (ESF) partners and regional and local experts has developed/updated a NYSDOH Medical Surge Plan based on Risk Assessment priorities. NYSDOH collaborated with AHPWG, ESF partners and regional and local experts to review and update the Pandemic Influenza plan. NYSDOH OHEP formed and hosted a workgroup with hospital preparedness staff from each of the four (4) HEPCs to identify areas for collaboration between hospitals and LHDs with volunteer recruitment, verification, and retention by June 30, 2025 (BP1). DHSES Office of Emergency Management (OEM) coordinated exercises with NYSDOH, Emergency Management (EM), Emergency Management System (EMS) and other State agencies to develop one (1) annual Integrated Preparedness Planning Workshop (IPPW) each BP. NYSDOH reviews and provides feedback to the HEPC training plans annually. NYSDOH OHEP collaborated with the HCC Readiness and Response Coordinators to review their existing inventory databases to update the state and regional Resource Inventory Assessment (RIA) report. The updated RIA report will be included in the HEPC's EOP and shared with HEPC members. NYSDOH OHEP in collaboration with HCC Readiness and Response Coordinators completed an annual review of the four (4) HEPC Continuity of Operations Plans (COOP). Clinical Advisors engaged in HEPC meetings and activities and validated HEPC EOP and other HEPC Plans based on identified Risk Assessment priorities. NYSDOH staff, HCC Readiness and Response Coordinators, trade associations and other relevant coalition partners convened statewide coalition strategic planning meeting to address mission, vision, and goals for new five-year cooperative agreement. NYSDOH OHEP in collaboration with HCC Readin”

“PREPARDNESS CONTD. 5. NYSDOH continues to support informatics infrastructure to provide electronic, secure systems and applications for emergency preparedness, response, and recovery. NYSDOH sustains and improves systems for information exchange and emergency communication. In-place architecture was leveraged, and new components have been added that link NYSDOH with its emergency preparedness and response partners and promote the exchange of data with stakeholders, bi-directionally, while ensuring appropriate privacy protection. Accomplishments from the period 04/01/2024 to 03/31/2025: NYSDOH Office of Primary Care and Health System Management (OPCHSM) progressed in the project of integrating of all NYS hospitals into the automated bed reporting and availability system. NYSDOH Informatics maintained the security and performance of the VHOC, a virtual platform used during an emergency or disaster event for coordination, communication, and documentation. NYSDOH Informatics provided monthly HCS, HERDS and IHANS trainings to State, regional and local partners throughout the project period. NYSDOH distributed a monthly Aware Prepare electronic newsletter to coalition members on upcoming trainings related to preparedness annually. NYSDOH Informatics maintained the security and performance of the Hospital Available Beds for Emergencies and Disasters (HAvBED) application, which is used for collection of hospital bed availability sent once or twice a day from hospitals through a secure data transfer system. NYSDOH Informatics maintained the security and performance of the Facility Evacuation Planning Application (FEPA), which allows facilities the ability to enter and modify patient counts by facility bed type to plan for patient movement in an event that the facility needs to be evacuated. NYSDOH used lessons learned from COVID-19, mpox, and other recent responses to identify and address gaps in Crisis and Emergency Risk Communication (CERC) activities that support communities of focus. NYHSDOH Informatics maintained the security and performance of the IHANS application, which is used to distribute messages to public health and healthcare personnel in NYS. NYSDOH Informatics maintained the security and performance of the State Repository of Emergency Volunteers New York (ServNY) application, which is a registry of healthcare and mental health professionals, who wish to volunteer during an emergency or major disaster. NYSDOH Informatics maintained the security and performance of the CDMS, an application that provides local, regional, state health departments and tribal nations with a single data reporting tool that may be used, regardless of the hazard or agent during a public health incident or event. NYSDOH Informatics maintained the security and performance of the Critical Specimen Transport and Coordination (CSTC) application, which is used to log and track critical specimen transportation requests when paper requests are not feasible. NYSDOH Informatics maintained the security and performance of the HERDS, Person-based Electronic Response Data System (PERDS), and Survey Management and Response Tool (SMART) applications, all which are used to create and collect data from participating HCS organizations. 6. NYSDOH OHEP builds public health emergency response capacity through extensive training offerings and close collaboration with LHDs, hospitals, and other partners. These trainings allow NYSDOH OHEP to enhance readiness and ensure that partners can receive any needed Technical Assistance (TA). In addition, NYSDOH OHEP conducts regular exercises to test different aspects of public health emergency response. Accomplishments from the period 04/01/2024 to 03/31/2025: Each of the four (4) HEPCs conducted a MRSE exercise to determine surge capacity among acute care beds and assess strengths and areas for improvement, then completed and submitted the MRSE Exercise Planning and Evaluation Tool. NYSDOH coordinated TA workshops with non-acu”

“PREPARDNESS CONTD. 7. NYSDOH continues to sustain and build public health laboratory testing capability of the NYSDOH Wadsworth Center (WC), to include testing of clinical, environmental, food and water samples. Laboratory testing continues to be a priority area including coordination and communication efforts and building additional capabilities. Laboratory Response Network (LRN)-Biological (B) goals include rapid testing using LRN protocols and reporting to submitters to provide information for prompt decision making. LRN-B will sustain the ability for contacting the sentinel laboratories in NYS through the HCS. LRN-Chemical (C) goals include the adoption of technology to process and maintain the positive identification of the large number of specimens that are handled during surge testing and to use the reference materials that are now supplied by the CDC for method improvement and the full validation of analytical protocols. Accomplishments from the period 04/01/2024 to 03/31/2025: The NYSDOH LRN-C laboratory produced and shipped Proficiency Testing (PT) materials for the Urine Metals panel (including mercury), and additionally Lewisite Metabolite-CVAA PT materials, on behalf of the CDC to State Public Health Laboratories (SPHLS) who participated in these test panels. The NYSDOH LRN-C laboratory shipped ten (10) PT challenge samples for each PT event, three (3) times a year (30 total challenge levels per year for each program, 60 levels for the two program), to up to 50 SPHLs. The NYSDOH LRN-C laboratory produced and shipped urine-based Quality Control (QC) materials for the Urine Metals panel, and Urine Mercury for up to 56 SPHLs (or the current number of LRN-C labs who participate in urine proficiency testing (PT) events). The NYS LRN-C laboratory characterized the new QC materials for homogeneity and stability; ship kits containing three (3) levels of QC materials and perform an initial statistical analysis based on our characterization data. Laboratory staff continued to serve as Subject Matter Experts (SME) for the urine metals, urine mercury and sulfur mustard metabolites assays. Staff led method training (CDC technology transfers) that were conducted in person, at the Biggs Laboratory, Albany, NY, site or remotely, per the CDCs guidance. The frequency of method training was determined by the CDC. The WC Biodefense Lab maintained and updated a list of clinical laboratories through the NYS Clinical Evaluation Program that could be called to assist with potential response events in which additional surge capacity is required. Participated in LRN-C Specimen Packaging and Shipping (SPaS) Exercise. Demonstrated proficiency in specimen shipping and packaging through the LRN-C SPaS exercises for chemical threat agents. Participated in annual challenge panels for PHEP-funded LRN-B laboratory capacity. Demonstrated proficiency in public health laboratory testing for biological agents by passing annual challenge panels that includes 1) Successfully identifying biothreat agents; 2) Demonstrating understanding of LRN agent-specific testing procedures and algorithms; 3) Ensuring a laboratory maintains appropriate levels of testing supplies and reagents. Participated in all LRN-C proficiency testing events for all LRN-C core and additional methods as defined by the LRN-C program office. Ensured that LRN-C Level 1 laboratories in NYS participated in all LRN-C proficiency testing events for all LRN-C core and additional methods as defined by the LRN-C program office. Ensured that LRN-C Level 2 laboratories in NYS participated in LRN-C proficiency testing events for all LRN-C core methods as defined by the LRN-C program office. Additional methods are optional for Level 2 laboratories. Passed proficiency exercises, core & additional as defined by LRN, to demonstrate LRN-C laboratory capacity. Implemented specified standards for electronic reporting of PHEP-funded LRN-B and LRN-C data for routine and emergency reporting. Reported resul”

“8. The NYSDOH continues to sustain and enhance its communicable disease surveillance systems that collect information from multiple data streams daily to ensure a baseline of epidemiologic data for NYS. NYSDOH continues to sustain the capability to analyze and interpret epidemiologic data that is critical to the practice of public health. Accomplishments from the period 04/01/2024 to 03/31/2025: NYSDOH Division of Epidemiology (DOE) conducted case investigation, contact tracing and community mitigation efforts. NYSDOH DOE Bureau of Surveillance and Data Systems maintained syndromic surveillance for bioterrorism-related events reporting through National Syndromic Surveillance Program (NSSP) ESSENCE tool and coordinate with CDC as needed. NYSDOH Office of Public Health (OPH) conducted complex analytic tasks, including models and forecasts using surveillance and other epidemiological data to characterize outbreak risk among different populations for public health leadership awareness and decision-making on emerging health issues. NYSDOH DOE Bureau of Surveillance and Data Systems enhanced the NYS Electronic Syndromic Surveillance System (ESSS) to include a Geographic Information System (GIS) and new disease syndromes and emerging threats as they arise to gather, manage, and analyze syndromic data across NYS. Data collected through the Electronical Clinical Laboratory Reporting System (ECLRS), the Communicable Disease Electronic Surveillance System (CDESS) and the ESSS to improve analytics and visualization of data to detect emerging threats and inform and evaluate interventions. New staff were trained as needed. Ideally, analytics used for the COVID-19 response were replicated for other critical diseases. 100% of outbreaks/events detected using advanced analytics triggered communicable disease investigations and implementation of appropriate control measures. NYSDOH DOE Bureau of Surveillance and Data Systems participated in the National Notifiable Disease Surveillance System (NNDSS) Modernization Initiative (NMI) working with the NMI technical team for updating and implementing HL7 disease case notification messages. The NYSDOH DOE Bureau of Surveillance and Data Systems will conduct gap analyses of current versus future messages, complete the onboarding process and validate data transmitted to CDC to help share lessons learned and best practices with other jurisdictions. 100% of notifiable diseases reported to CDC were used disease specific HL7 messaging. NYSDOH DOE Bureau of Communicable Disease Control evaluated all Category A and Category B disease case reports to ensure that investigations were completed, and appropriate control measures were implemented. NYSDOH incorporated IHANS into notification drills for the CRI identified counties, NYSDOH MCM critical contact, and Preparedness Surge Staff. NYSDOH DOE Bureau of Communicable Disease Control evaluated all disease reports to ensure that timely investigations were initiated for Category I, Category II, and Category III agents. NYSDOH DOE Bureau of Communicable Disease Control prepared and disseminate annual progress performance reports on timeliness and completeness of communicable disease investigations to LHDs. All 57 (100%) LHDs received an individualized report to compare achievement with other counties within the same geographic region and similar population size to form a Common Operating Picture (COP) of disease surveillance statewide. Program Period Successes: NYSDOH OHEP has worked with the four HPP Healthcare Coalitions to provide a total of seven (7) TTX focused on the activation and operation of CHEMPACK across NYS. These exercises have led to in-depth discussions of key response elements of the CHEMPACK program, from initial identification of a hazard requiring CHEMPACK, notification of critical partners involved in response, transportation of assets, cross jurisdictional collaboration, to demobilization and return to readiness of CHEMPACK assets. The exercise”

“Roswell Park Cancer Institute is a multidisciplinary, translational comprehensive cancer center, with a mission to eliminate cancer's grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. RPCI utilizes its comprehensive cancer support grant (CCSG) through HRI to build on unique strengths and opportunities, moving laboratory science into advanced treatment, prevention, diagnosis, and education. Roswell Park Cancer Institute's revolutionary research model of a "multidisciplinary approach" to cancer with scientists and clinicians working in concert and in consult has become the standard by which all modern-day comprehensive cancer centers are measured. HRI continues to work with RPCI leadership in all of their research endeavors. HRI's cancer research grant portfolio supports a nationally recognized research enterprise at RPCI. The Buffalo comprehensive cancer center is one of only 56 comprehensive cancer centers in the country. Health Research Incorporated (HRI) provides effective pre-and-post-award evaluation, solicitation, and administration of external research support from Federal and State agencies, not-for-profit foundations, and commercial firms in accordance with the requirements of the sponsor. The HRI/Grants Management staff (22 FTES) support active research related projects for RPCI, providing timely and detailed revenue and expenditure information for internal and external review, as well as analysis with Institute investigators. HRI-Roswell Park Division currently has active projects totaling $147.84 million. HRI-Roswell Park's largest sponsor is the National Institute of Health (NIH) representing more than 33% of total funding.”

“Office of Public Health Office of Health Services Quality and Analytics Office of Primary Care Health Systems Management Office of the Commissioner School of Public Health Office of Aging and Long Term Care”

“US Treasuries & Securities FMV = $548,082,497”

“There have been no changes made to the oversight and selection process during the tax prep year.”